Aetiologies and contributing factors of vulvovaginal candidiasis in Abidjan (Cote d’Ivoire)

Abauleth, 2006, Étiologie et prise en charge thérapeutique des leucorrhées infectieuses au CHU de Cocody (Abidjan, Côte d’Ivoire), Santé (Montrouge), 16, 191 Amouri, 2010, La candidose vulvovaginale : revue, J Mycol Med, 20, 108, 10.1016/j.mycmed.2010.01.005 Anane, 2010, Les candidoses vulvovaginales : facteurs de risque et particularités cliniques et mycologiques, J Mycol Med, 20, 36, 10.1016/j.mycmed.2010.01.001 Anis, 2009, Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India, Eur J Obstet Gynecol Reprod Biol, 144, 68, 10.1016/j.ejogrb.2008.12.020 Bauters, 2002, Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women, Am J Obstet Gynecol, 187, 569, 10.1067/mob.2002.125897 Benchellal, 2011, La candidose vulvovaginale à l’hôpital militaire d’instruction Mohammed V (Maroc), J Mycol Med, 21, 106, 10.1016/j.mycmed.2011.03.003 Bohannon, 1998, Treatment of vulvovaginal candidiasis in patients with diabetes, Diabetes Care, 21, 451, 10.2337/diacare.21.3.451 Chassot, 2008, Can intrauterine contraceptive devices be a Candida albicans reservoir?, Contraception, 77, 355, 10.1016/j.contraception.2008.01.007 De Leon, 2002, Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes, BMC Infectious Dis, 2, 1, 10.1186/1471-2334-2-1 Djohan, 2012, Sensibilité in vitro des souches de Candida albicans d’origine vaginale aux antifongiques à Abidjan (Côte d’Ivoire), J Mycol Med, 22, 129, 10.1016/j.mycmed.2011.11.005 Eckert, 1998, Clinical manifestations, risk factors, management algorithm, Obstet Gynecol, 92, 757 Foxman, 1990, The epidemiology of vulvovaginal candidiasis: risk factors, Am J Public Health, 80, 329, 10.2105/AJPH.80.3.329 Glover, 2003, Relationship of fungal vaginitis therapy to prior antibiotic exposure, Infect Dis Obstet Gynecol, 11, 57, 10.1080/10647440300025514 Grigoriou, 2006, Prevalence of clinical vaginal candidiasis in a university hospital and possible risk factors, Eur J Obstet Gynecol Reprod Biol, 126, 121, 10.1016/j.ejogrb.2005.09.015 Guelzim, 2004, Épidémiologie des candidoses vaginales à Mitrovica, Kosovo, Rev Int Serv Force Armées, 77, 261 Hasna, 2012, Sensibilité in vitro des souches de Candida albicans d’origine vaginale aux antifongiques chez une population marocaine consultant à l’Institut Pasteur du Maroc, Eur J Sci Res, 80, 109 Hurley, 1979, Candida vaginitis, Postgrad Med J, 55, 645, 10.1136/pgmj.55.647.645 Jindal, 2007, An epidemiological study of vulvovaginal candidiasis in women of childbearing age, Indian J Med Microbiol, 25, 175, 10.4103/0255-0857.32736 Karaer, 2005, Vaginitis in Turkish women: symptoms, epidemiologic-microbiologic association, Eur J Obstet Gynecol Reprod Biol, 121, 211, 10.1016/j.ejogrb.2004.11.030 Kassi, 1995, Étiologies fongique et parasitaire des vulvo-vaginites à Abidjan, Med Afr Noire, 42, 233 Kunzelmann, 1996, Prerequisites for effective therapy of chronic recurrent vaginal candidiasis, Mycoses, 39, 65, 10.1111/j.1439-0507.1996.tb00508.x Malazy, 2007, Vulvovaginal candidiasis and its related factors in diabetic women, Taiwan J Obstet Gynecol, 46, 399, 10.1016/S1028-4559(08)60010-8 Menan, 2008, Recherche de Candida dubliniensis chez des patients VIH+ à Abidjan (Côte d’Ivoire), J Mycol Med, 18, 228, 10.1016/j.mycmed.2008.10.001 Moreira, 2006, Vulvovaginal candidiasis, Int J Gynecol Obstet, 92, 266, 10.1016/j.ijgo.2005.12.007 Nyirjesy, 2003, Vulvovaginal candidiasis, Obstet Gynecol Clin N Am, 30, 671, 10.1016/S0889-8545(03)00083-4 Powell, 1983, Confirmation of corticosterone and progesterone binding activity in Candida albicans, J Infect Dis, 147, 359, 10.1093/infdis/147.2.359 Richter, 2005, Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases, J Clin Microbiol, 43, 2155, 10.1128/JCM.43.5.2155-2162.2005 Ringdahl, 2000, Treatment of recurrent vulvovaginal candidiasis, Am Fam Physician, 61, 3306 Rowe, 1990, Is candidiasis the true cause of vulvovaginal irritation in women with diabetes mellitus?, J Clin Pathol, 43, 644, 10.1136/jcp.43.8.644 Rylander, 2004, Vulvovaginal Candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse, Sex Transm Infect, 80, 54, 10.1136/sti.2003.004192 Senterre, 2005, Prévalence des différentes espèces de Candida au niveau vaginal dans la région Liégeoise, Rev Med Liege, 60, 882 Sobel, 1988, Pathogenesis and epidemiology of vulvovaginal candidiasis, Ann N Y Acad Sci, 544, 547, 10.1111/j.1749-6632.1988.tb40450.x Sobel, 1992, Pathogenesis and treatment of recurrent vulvovaginal candidiasis, Clin Infect Dis, 14, S148, 10.1093/clinids/14.Supplement_1.S148 Sobel, 1998, Vulvovaginitis due to Candida glabrata an emerging problem, Mycoses Probl, 41, 18, 10.1111/j.1439-0507.1998.tb00594.x Sobel, 2007, Vulvovaginal candidosis, Lancet, 369, 1961, 10.1016/S0140-6736(07)60917-9 Sobel, 1998, Vulvovaginal candidiasis: epidemiologic, diagnostic and therapeutic considerations, Am J Obstet Gynecol, 178, 203, 10.1016/S0002-9378(98)80001-X Spinillo, 1995, Torulopsis glabrata vaginitis, Obstet Gynecol, 85, 993, 10.1016/0029-7844(95)00047-U